HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Cancer Epidemiologists

Cancer Epidemiologists study patterns, causes, and effects of cancer within populations to better understand how and why the disease develops and spreads. By analyzing large sets of health data, they identify risk factors such as genetics, lifestyle, environmental exposures, and socioeconomic conditions that influence cancer incidence and outcomes. Their research plays a crucial role in shaping public health policies, prevention programs, and screening guidelines aimed at reducing the burden of cancer.

These professionals often work in collaboration with clinicians, biostatisticians, and public health agencies to design and implement population-based studies and clinical trials. They investigate disparities in cancer rates among different groups, monitor trends over time, and evaluate the effectiveness of interventions like vaccination or early detection efforts. Their findings help determine which populations are most at risk and how to allocate resources more effectively. Cancer epidemiologists are also instrumental in assessing the long-term impacts of treatment and survivorship. Their work directly informs strategies for prevention, education, and early detection that can lead to lower cancer mortality rates. By identifying emerging trends and novel risk factors, they also help guide future cancer research and healthcare initiatives. Through careful analysis and evidence-based insight, cancer epidemiologists contribute to a deeper understanding of cancer on a societal level—turning data into action that benefits both individuals and communities.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp